Clinical Trial Update: FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial update for FHD-286 as monotherapy or in combination in adults with advanced hematologic malignancies. The study is currently active and not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• FHD-286

Snippet

Sponsor: Foghorn Therapeutics Inc. | Conditions: Advanced Hematologic Malignancy, Relapsed Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING